The construction, prediction and measurement of co-crystal ternary phase diagrams as a tool for solvent selection

[Display omitted] Many active pharmaceutical ingredients (APIs) are poorly soluble and therefore poorly bioavailable. In recent years, the advances in crystal engineering have motivated the research in the design of pharmaceutical co-crystals. This study examines the combination of solvent selection...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutical sciences Vol. 63; pp. 124 - 131
Main Authors Holaň, Jan, Štěpánek, František, Billot, Pascal, Ridvan, Luděk
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 15.10.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] Many active pharmaceutical ingredients (APIs) are poorly soluble and therefore poorly bioavailable. In recent years, the advances in crystal engineering have motivated the research in the design of pharmaceutical co-crystals. This study examines the combination of solvent selection and co-crystal ternary phase diagram prediction on the basis of solubility measurements into a single methodology that can be integrated into the pharmaceutical process development workflow. Ternary diagrams constructed from agomelatine citric acid co-crystal solubility data were compared with those obtained by modern calorimetric method called discontinuous isoperibolic thermal analysis (DITA). A suitable solvent for the co-crystallization process has been chosen on the basis of agomelatine citric acid co-crystal solubility, which is connected to the yield of the crystallization process. Furthermore, the quality of final crystals from crystallization experiments was evaluated.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0928-0987
1879-0720
DOI:10.1016/j.ejps.2014.06.017